Cargando…
Tissue Factor-Targeted “O(2)-Evolving” Nanoparticles for Photodynamic Therapy in Malignant Lymphoma
Vascular-targeted PDT (vPDT) has produced promising results in the treatment of many cancers, including drug-resistant ones, but little is known about its efficacy in lymphoma. Unfortunately, the lack of a specific therapeutic target and a hypoxic microenvironment for lymphoma jeopardizes the effica...
Autores principales: | Li, Ziying, Yin, Yanxue, Jin, Weiwei, Zhang, Bo, Yan, Han, Mei, Heng, Wang, Huafang, Guo, Tao, Shi, Wei, Hu, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683716/ https://www.ncbi.nlm.nih.gov/pubmed/33240803 http://dx.doi.org/10.3389/fonc.2020.524712 |
Ejemplares similares
-
A tissue factor-cascade-targeted strategy to tumor vasculature: a combination of EGFP-EGF1 conjugation nanoparticles with photodynamic therapy
por: Shi, Wei, et al.
Publicado: (2016) -
Correction: A tissue factor-cascade-targeted strategy to tumor vasculature: a combination of EGFP-EGF1 conjugation nanoparticles with photodynamic therapy
por: Shi, Wei, et al.
Publicado: (2018) -
From CAR-T Cells to CAR-NK Cells: A Developing Immunotherapy Method for Hematological Malignancies
por: Lu, Hui, et al.
Publicado: (2021) -
Photodynamic therapy for malignant brain tumors in children and young adolescents
por: Chiba, Kentaro, et al.
Publicado: (2022) -
Corrigendum: Photodynamic therapy for malignant brain tumors in children and young adolescents
por: Chiba, Kentaro, et al.
Publicado: (2023)